Divis Laboratories’ unit-1 at vill., Lingojigudem, Choutuppal Mandal near Hyderabad had been inspected by the US-FDA. The intention of this inspection was for product pre-approval and general current good manufacturing practices. The audit concluded with minor observations primarily about additional records for further improvement of existing records.
The company has registered a growth of 26.55% in its net profit for the year ended March 31, 2011 at Rs 435.57 crore as compared to Rs 344.20 crore for the year ended March 31, 2010. Its total income has increased by 40.00% at Rs 1344.04 crore for the year from Rs 959.98 crore in previous year.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: